BioLife Solutions
BLFS
165 hedge funds and large institutions have $1.34B invested in BioLife Solutions in 2021 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 11 closing their positions.
300% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 11
128% more call options, than puts
Call options by funds: $2.77M | Put options by funds: $1.22M
25% more funds holding
Funds holding: 132 → 165 (+33)
15% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 46
8% more capital invested
Capital invested by funds: $1.24B → $1.34B (+$97.8M)
7.77% more ownership
Funds ownership: 69.19% → 76.96% (+7.8%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$112M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.1M |
| 3 |
State Street
Boston,
Massachusetts
|
+$13.7M |
| 4 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$13.7M |
| 5 |
MAP
Moody Aldrich Partners
Marblehead,
Massachusetts
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$31.2M |
| 2 |
Millennium Management
New York
|
-$23.7M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$22.8M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$6.06M |
| 5 |
SCM
Sandler Capital Management
New York
|
-$5.73M |
BLFS Hedge Fund Activity: Q3 2021 in Review
165 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2021, worth a combined $1.34B — up 7.9% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new BLFS positions and 11 closed out — a net gain of 33 holders — while 53 added to existing stakes and 46 trimmed.
The largest buyer was BlackRock, adding an estimated $112M. The largest seller was Wasatch Advisors, cutting an estimated $31.2M.
- 165 institutional investors held BioLife Solutions (BLFS) as of Q3 2021, up from 132 in Q2 2021.
- Funds reported $1.34B of BioLife Solutions stock for Q3 2021, up 7.9% quarter-over-quarter.
- 44 funds opened new BioLife Solutions positions in Q3 2021 and 11 closed out, a net change of +33 holders.
- The largest BioLife Solutions buyer in Q3 2021 was BlackRock, an estimated $112M added.
- The largest BioLife Solutions seller in Q3 2021 was Wasatch Advisors, an estimated $31.2M sold.
Based on aggregated 13F filings for Q3 2021.